Insurance stocks are topping the IBD 50 as investors turn to more defensive names as former leading growth stocks continue to ...

Compounding pharmacy and IBD 50 newcomer Hims & Hers Health reported bullish earnings and sales growth late Monday. But Hims stock tanked. Please watch the video at Investors.com - The Weight-Loss ...

The IBD 50 has enjoyed a long stretch of terrific returns but the ETF based on it has struggled since its launch. The IBD 50 has enjoyed a long stretch of terrific returns but the ETF based on it ...

I believe there is a good chance they will recover when management states that fundamentals are unchanged and they are progressing well.

37,249 people played the daily Crossword recently. Can you solve it faster than others?37,249 people played the daily Crossword recently. Can you solve it faster than others?

Doctors may use blood, stool, and imaging tests to help diagnose IBD. However, endoscopy with biopsy is often essential to confirming a diagnosis and distinguishing between the two types.

for all patients ages 50 and older who took ustekinumab or vedolizumab for IBD from 2015 to 2024. They used propensity score matching to match 2,286 patients taking ustekinumab with 2,286 patients ...

Chan and colleagues used deidentified electronic health record data from TriNetX to compare the risk for major adverse cardiovascular events among patients with IBD aged 50 years and older treated ...

The broad market exchange-traded fund SPDR S&P 500 ETF Trust (SPY) was up 0.3% and the actively trad NVIDIA reports blockbuster fourth-quarter fiscal 2025 results powered by new AI Blackwell chips ...

Data Disclaimer: The Nasdaq Indices and the Major Indices are delayed at least 1 minute. Sign up for the TradeTalks newsletter to receive your weekly dose of trading news, trends and education ...

The overall quant rating is not an average of the factor grades listed. Instead, it gives greater weight to the metrics with the strongest predictive value.